Abstract
Tobacco produces dependence or addiction in humans. Dependence can be defined as a maladaptive pattern of substance use or drug taking over an extended time period. The American Psychiatric Association, in its DSM-IV manual for psychiatric diagnosis (1), suggest an operative diagnosis of tobacco dependence when three or more of the following seven symptoms or signs are identified in a subject:
-
1.
Persistent desire and unsuccessful attempts to quit
-
2.
Use of large amounts of drug and for a longer period than intended
-
3.
Continued use in the face of medical, familial, and social problems
-
4.
Important social, familial, and recreational activities given up or reduced because of drug craving
-
5.
Expenditure of a great deal of time and activity in relation to drugs
-
6.
Tolerance
-
7.
Physical dependence (withdrawal)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders, DSM-IV. American Psychiatric Association, Washington, DC.
Jarvik, M. E. (1995) Commentary. Psychopharmacology 117,18–20.
US Department of Health, Education and Welfare. (1964) Smoking and Health. Report of the advisory committee to the Surgeon General of the Public Health Service, Maryland.
US Department of Health and Human Services. (1988) The Health Consequences of Smoking, Nicotine Addiction. A Report of the Surgeon General, Office of Smoking and Health, Bethesda, Maryland.
O’Brien, C. P. (1996) Drug addiction and drug abuse, in The Pharmacological Basis of Therapeutics (Goodman, L. S. and Gilman, P. R., eds.), McGraw-Hill, New York, pp. 276–282.
Stolerman, I. P. and Jarvis, M. J. (1995) The scientific case that nicotine is addictive. Psychopharmacology 117, 2–10.
Domino, E. F. (1997) Tobacco smoking and nicotine neuropsychopharmacology, some future research directions. Neuropsychopharmacology 18, 456–468.
Stolerman, I. P. (1992) Drug of abuse, behavioral principles, methods and term. TIPS 13, 170–176.
Koob, G. F. and Le Moal, M. (1997) Drug abuse, hedonic homeostatic dysregulation. Science 278, 52–58.
Di Chiara, G. (2000) Behavioral pharmacology and neurobiology of nicotine reward and dependence, in Handbook of Experimental Pharmacology, vol. 144, (Clementi, F., Fomasari, D., and Gotti, C., eds.), Neural Nicotinic Receptors, Springer-Verlag, Berlin, Heidelberg, pp. 603–750.
Hennigfield, J. E. and Goldberg, S. R. (1983) Control of behavior by intravenous injection of nicotine in human subjects. Pharmacol. Physiol. Behay. 19,1021–1026.
Altman, J., Everitt, B. J., Glautier, S., Markou, A., Nutt, D., Oretti, R., Phillips, G. D., and Robbins T. W. (1996) The biological, social, and clinical bases of drug addiction, commentary and debate. Psychopharmacology 125, 285–345.
Koob, G. F. (1992) Drug of abuse, anatomy, pharmacology and function of reward pathways. TIPS 13, 177–184.
Corrigall, W. A. (1999) Nicotine self-administration in animal as a dependence model. Nicotine & Tobacco Res. 1, 11–20.
Olds, J. and Milner, P. M. (1954) Positive reinforcement produced by electrical stimulation of septal area and other regions of the rat brain. J. Comp. Pshysiol. Psychol. 47, 419–427.
Wise, R. A. (1996) Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243–251.
Schaefer, G. J. and Michael, R. P. (1986) Task-specific effects of nicotine in rats, intracranial self-stimulation and locomotor activity. Neuropharmacology 25, 125–131.
Huston-Lyon, D. and Kornetski, C. (1992) Effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacol. Biochem. Behay. 41, 755–759.
Bauco, P. and Wise, R. A. (1994) Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine, examination of repeated treatment. J. Pharmacol. Exp. Ther. 271, 294–301.
Robbins, T. W.,and Everitt, B. J. (1996) Neurobehavioral mechanisms of reward and motivation. Curr. Opin. Neurobiol. 6, 228–256.
Kreek, M. J. and Koob, G. F. (1998) Drug dependence, stress and dysregulation of brain reward pathways. Drug & Alcohol Dependence 51, 23–47.
White, N. M. (1996) Addictive drugs as reinforcers, multiple partial actions on memory system. Addiction 91, 921–946.
Cador, M., Robbins, T. W., and Everitt, B. J. (1989) Involvement of amygdala in stimulusreward association, interaction with the ventral striatum. Neuroscience 30, 77–86.
White, N. M. and Hiroi, N. (1993) Amphetamine conditioned cue preference and the neurobiology of drug seeking. Semin. Neurosci. 5, 329–336.
Tiffani, S. T. (1990) A cognitive model of drug urges and drug-use behavior, role of automatic and nonautomatic processes. Psychol. Rev. 97, 147–168.
Chiamulera, C., Borgo, C., Falchetto, S., Valerio, E., and Tessari, M. (1996) Nicotine reinstatement of nicotine self-administration after long term extinction. Psychopharmacology 127, 102–107.
Shaham, Y., Adamson, L. K., Grocki, S., and Corrigall, W. A. (1997) Reinstatement and spontaneous recovery of nicotine seeking in rats. Psychopharmacology 130, 396–403.
Snyder, F. R., Davis, F. C., and Henningfield, J. E. (1989) The tobacco withdrawal syndrome, performance decrements assessed on computerised test battery. Drug Alcohol Depend. 23, 259–266.
Malin, D. H., Lake, J. R., Carter, V. A., Cunningham, J. S., and Wilson, O. B. (1993) Naloxone precipitates nicotien abstinence syndrome in the rat. Psychopharmacology 112, 339–342.
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., and Markou, A. (1998) Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393, 76–79.
Markou, A., Kosten, T. R., and Koob, G. F. (1998) Neurobiological similarities in depression and drug dependence: a self—medication hypothesis. Neuropsychopharmacology 18, 135–174.
Fagernstrom, K. O. (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Add. Behay. 3, 235–241.
Watkins, S. S., Koob, G. F., and Markou A. (2000) Neural mechanisms underlying nicotine addiction, acute positive reinforcement and withdrawal. Nicotine & Tobacco Res. 2, 19–37.
Spealman, R. D. (1983) Maintenance of behavior by postponement of scheduled injections of nicotine in squirrel monkeys. J. Pharmacol. Exp. Ther. 227, 154–159.
Irvine, E. E., Bagnalasta, M., Marcon, C., Motta, C., Tessari, M., File, S. E., and Chiamulera, C. (2001) Nicotine self-administration and withdrawal, modulation of anxiety in the social interaction test in rats. Psychopharmacologia 153, 315–320.
Singer, G., Simpson, F., and Lang, W. J. (1978) Schedule induced self-injections of nicotine with recovered body weight. Pharmacol. Biochem. Behay. 9, 387–389.
Latiff, A. A., Smith, L. A., and Lang, W. J. (1980) Effects of changing dosage and urinary pH in rats self-administering nicotine on a food delivery schedule. Pharmacol. Biochem. Behay. 13, 209–213.
Smith, L.A. and Lang, W.J. (1980) Changes occuring in self-administration of nicotine by rats over a 28-day period. Pharmacol. Biochem. Behay. 13, 215–220.
Goldberg, S. R., Spealman, R. D., and Goldberg D. M. (1981) Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 214, 573–575.
Cox, B. M., Goldstein, A., and Nelson, W. T. (1984) Nicotine self-administration in rats. Br. J. Pharmacol. 83, 49–55.
Corrigall, W. A. and Coen, K. M. (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99, 473–478.
Tessari, M., Valerio, E., Chiamulera, C., and Beardsley, P. M. (1995) Nicotine reinforcement in rats with histories of cocaine self-administration. Psychopharmacology 121, 282–283.
Shoaib, M., Schindler, C. W., and Goldberg, S. R. (1997) Nicotine self-administration in rats, strain, and nicotine pre-exposure effects on acquisition. Psychopharmacology 129, 35–43.
Donny, E. C., Caggiula, A. R., Mielke, M. M., Jacobs, K. S., Rose, C., and Sved, A. F. (1998) Acquisition of nicotine self-administration in rats, the effects of dose, feeding schedule, and drug contingency. Psychopharmacology 136, 83–90.
Dworkin, S. I., Vrana, S. L., Broadbent, J., and Robinson, J. H. (1993) Comparing the reinforcing effects of nicotine, caffeine, methylphenidate and cocaine. Med. Chem. Res. 2, 593–602.
Valentine, J. D., Hokanson, J. S., Matta, S. G., and Sharp, B. M. (1997) Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology 133, 300–304.
Koob, G. F. (1995) Animal models of drug addiction, in Pschopharmacology, The Fourth Generation of Progress. (Bloom, F. E. and Kupfler, D. J., eds.), Raven Press, New York, pp. 759–772.
Goldberg, S. R. and Gardner, M. L. (1981) Second-order schedules, extended sequences of behavior controlled by brief environmental stimuli associated with drug self-administration. NIDA Res. Monogr. Ser. 37, 241–270.
Rasmussen, T. and Swedberg, M. D. B. (1998) Reinforcing effects of nicotine compounds, intravenous self-administration in drug-naïve mice. Pharmacol. Biochem. Behay. 60, 567–573.
Stolerman, I. P., Naylor, C., Elmer, G. I., and Goldberg, S. R. (1999) Discrimination and selfadministration of nicotine by inbred strains of mice. Psychopharmacology 141, 297–306.
Picciotto, M. R., Zoli, M., Rimondini, R., Lena, C., Marubio, L., Merlo Pich, E., Fuxe, K., and Changeux, J. P. (1998) Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173–177.
Merlo-Pich, E. and Epping-Jordan, M. P. (1998) Transgenic mice in drug dependence research. Ann. Med. 30, 390–396.
Changeux, J.-P., Bertrand, D., Corringer, P. J., Dehaene, S., Edelstein, S., Lena, C., Le Novere, N., Marubio, L., Picciotto, M., and Zoli, M. (1998) Brain nicotinic receptors, structure and regulation, role in learning and reinforcement. Brain Res. Rev. 26, 198–216.
Colquhoun, L. M. and Patrick, J. W. (1997) Pharmacology of neuronal nicotinic acetylcholine receptor subtypes. Adv. Pharmacol. 39,191–220.
Clarke, P. B. S., Schwartz, R. D., Paul, S. M., Pert, C. B., and Pert, A. (1985) Nicotine binding in rat brain, autoradiography comparison of 3H-acetylcholine, 3H-nicotine and 125I-αbungarotoxine. J. Neurosci. 5, 1307–1315.
Orr-Uteger, A., Galdner, F. M., Saeki, M., Lorenzo, I., Goldberg, L., De Blasi, M., Dani, J. A., Patrick, J. K., and Beaudet, A. L. (1997) Mice deficent of the a7 neuronal nicotinic acethylcoline receptor lack a—bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci. 17, 9165–9171.
Zoli, M., Lena, C., Picciotto, M., and Changeux, J.-P. (1998) Identification of four classes of brain nicotinic receptors using β2 mutant mice. J. Neurosci. 18, 4461–4472.
Marubio, L. M., Arroyo-Jimenez, M. M., Cordero-Erausquin, M., Lena, C., Le Novere, N., de Kerchove d’Exaert, A., Huchet, M., Damaj, M. I., and Changeux, J.-P. (1999) Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398, 805–809.
Mulle, C., Vidal, C., Benoit, P., and Changeux, J.-P. (1991) Exsitence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo—interpeduncular system. J. Neurosci. 11, 2588–2597.
Benwell, M. E. M., Balfour, D. J. K., and Anderson, J. M. (1988) Evidence that tobacco smoking increases the density of (-)3H-nicotine binding site in human brain. J. Neurochem. 50, 1243–1247.
Breese, C. R., Marks, M. J., Logel, J., Adams, C. E., Sullivan, B., Collins, A. C., and Leonard, S. (1997) Effects of smoking history on 3H—nicotine binding in human post—mortem brain. J. Pharmacol. Exp. Ther. 255, 187–196.
Court, J. A., Lloyd, S., Thomas, N., Piggot, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., and Perry, E. K. (1998) Dopamine and nicotinic receptor binding and the level of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 87, 63–78.
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., and Kellar, K. J. (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up— regulated by chronic nicotine treatment. Mol. Pharmacol. 41, 31–37.
Flores, C. M., Davila-Garcia, M. I., Ulrich, Y. M., and Kellar, K. J. (1997) Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J.. Neurochem. 69, 2216–2219.
Marks, M. J., Pauly, J. R., Gross, S. D., Deneris, E. S., Hermans-Borgmeyer, I., and Collins, A. C. (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12, 2765–2784.
Marks, M. J., Grady, S. R., Yang, J. M., Lippiello, P. M., and Collins A. C. (1983) Desensitisation of nicotine-stimulated 86RB efflux from mouse brain synaptosome. J. Neurochem. 63, 2125–2135.
Wang, F., Nelson, M. E., Kuryatov, A., Olale, F., Cooper, J., Keyser, K., and Lindstrom, J. (1998) Chronic nicotine treatment up—regulated human 0β4 but not acetylcholine receptors stably transfected in human embryonic kidney cells. J. Biol. Chem. 273, 28731–28732.
Robinson, T. E. and Berridge, K. C. (1993) The neural basis of drug craving, an incentivesensitisation theory of addiction. Brain Res. Rev. 18, 247–291.
Nestler, E. J. (1996) Under siege, the brain on opiates. Neuron 16, 897–900.
LeNovere, N., Zoli, M., and Changeux, J. P. (1996) Neuronal nicotinic receptors alpha-6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci. 8, 2428–2433.
Arroyo-Jimenez, M. M., Bourgeois, J.-P., Marubio, L. M., Le Sourd, A. M., Ottersenn, O. P., Rinvik, P., Faire, A., and Changeux, J.-P., (1999) Ultrastructural localization of the α4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra. J. Neurosci. 19, 6475–6487.
Calabresi, P., Lacey, M. G., and North, R. A. (1989) Nicotine excitation of rat ventral tegmental neurons in vitro studied by intracellular recording. Br. J. Pharmacol. 98, 135–140.
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., and Dani J. D. (1997) Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390, 401–404.
Mereu, G., Yoon, K. W. P., Boi, V., Gessa, G. L., Naes, L., and Wesfall, T. C. (1987) Preferential stimulation of ventral tegmental areas dopaminergic neurons by nicotine. Eur. J. Pharmacol. 141, 395–399.
Anderson, K., Fuxe, K., and Agnati, L. F. (1981) Effects of single injection of nicotine on the ascending dopaminergic pathways in the rats. Evidence for increase dopamine turnover in the mesostriatal and mesolimbic dopamine neurones. Acta Physiol. Scand. 112, 345–347.
Fuxe, K., Andersson, K., Harfstrand, A., and Agnati, L. F. (1986) Increase dopamine utilisation in certain limbic dopamine terminal populations after short period of intermittent exposure to male rats to cigarette smoke. J. Neural. Transm. 67, 15–29.
Imperato, A., Mulas, A., and Di Chiara, G. (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132, 337–338.
Balfour, D. J. K., Benwell, M. E. M., Birrel, C. E., Kelly, R. J., and Al-Aloul M. (1998) Sensitisation of measoaccumbens dopamine response to nicotine. Pharmacol. Biochem. Behay. 59, 1021–1030.
Pontieri, F. E., Tanda, G., Orzi, F., and Di Chiara, G. (1997) Effects of nicotine on the nucleus accumbens and similarities to those of addictive drugs. Nature 382, 255–257.
Nisell, M., Nomikos, G. G., and Svensson T. H. (1994) Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16, 36–44.
Chergui, K., Charlety, P. J., Akaoka, H., Saunier, C. F., Brunet, J. L., Buda, M., Svensson, T. H., and Chovet, G. (1993) Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur. J. Neurosci. 5, 137–144.
Gonon, F. G. (1988) Nonlinear relationship between impulse flow and dopamine released by rats midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24, 19–28.
Benwell, M. E. M., Balfour, D. J. K., and Birrel, C. E. (1995) Desensitisation of nicotineinduced dopamine response during constant infusion with nicotine. Br. J. Pharmacol. 114, 211–217.
Hildebrand, B. E., Nomikos, G. G., Hertel, P., Schilstrom, B., Swensson, T. H. (1997) Reduced dopamine output in nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine—precipitated withdrawal syndrome. Brain Res. 779, 214–225.
Carboni, E., Bortone, L., Giva, C., and Di Chiara, G. (2000) Dissociation of physical abstinence sign from changes in extracellular dopamine in the nucleus accumbens and in the prefronatal cortex of nicotine dependent rats. Drug Alcohol Dep. 58, 93–102.
Marshall, D. L., Redfern, P. H., and Wonnacott, S. (1997) Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdalysis, comparison of naive and chronic nicotine-treated rats. J. Neurochem. 68, 1511–1519.
Wonnacott, S., Soliakov, L., Wilke, G., Redfern, P., and Marshall, D. (1996) Presynaptic nicotine acetylcholine receptors in the brain. Drug Develop. Res. 38, 149–159.
Grady, S. R., Marks, M. J., and Collins, A. C. (1994) Desensitisation of nicotine-stimulated 3H-dopamine release from mouse striatal synaptosomes. J. Neurochem. 62, 1390–1398.
Yu, Y. J. and Wecker, L. (1994) Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices. J. Neurochem, 63, 186–194.
Schilstrom, B., Svensson, H. M., Svensson, T. H., and Nomikos, G. G. (1998) Nicotine and food induced dopamine release in the nucleus accumbens of the rat, putative role of a7 nicotinic receptors in the ventral tegmental area. Neuroscience 85, 1005–1009.
Nomikos, G. G., Schilstrom, B., Hildebrand, B. E., Panagis, G., Grenhoff, J., and Svensson, T. H. (2000) Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. Behay. Brain Res. 113, 97–103.
Brioni, J. D., Kim, D. J., and O’Neill, A. B. (1996) Nicotine cue, lack of the effect of a7 nicotinic receptor antagonist methyllycaconitine. Eur. J. Pharmacol. 301, 1–5.
Carr, L. A., Rowell, P. P., and Pierce, W. M., Jr. (1989) Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat. Neurochem. Res. 14, 511–515.
Smith, K. M., Mitchell, S. N., and Joseph, M. H. (1991) Effects of chronic and subchronic nicotine on tyrosine-hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J. Neurochem. 57, 1750–1756.
Corrigall, W. A. and Coen, K. M. (1991) Selective dopamine antagonists reduce nicotine selfadministration. Psychopharmacology 104, 171–176.
Corrigal, W. A., Franklin, K. B. J., Coen, K. M., and Clarke, P. B. S. (1992) The mesolimbic dopamine system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107, 285–289.
Dawe, S., Giarada, C., Russel, M. A. H., and Gray, J. A. (1995) Nicotine intake in smokers increases following single dose of haloperidol. Psychopharmacology 117, 110–116.
Hurt, R. D., Sachs, D. P. L., and Glover, E. D. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N. Engl. J. Med. 337, 1195–1202.
Corrigall, W. A., Coen, K. M., and Adamson, K. L. (1994) Self-administration of nicotine activates the mesolimbic nicotine system through the ventral tegmental area. Brain Res. 653, 278–284.
Hope, B. T., Nye, H. E., Kelz, M. B., Self, D. W., Iadarola, M. J., Nakabeppu, Y., Duman, R. S., and Nestler, E. J. (1994) Induction of a long-lating AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatment. Neuron 13, 1235–1244.
Harlan, R. E. and Garcia, M. M. (1998) Drug of abuse and immediate-early genes in the forebrain. Mol. Neurobiol. 16, 221–267.
Hughes, P. and Dragunow, M. (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47,133–178.
Ren, T. and Segar, S. M. (1992) Induction of c-fos immunostaining in the rat brain after the systemic administration of nicotine. Brain Res. Bull. 29, 589–597.
Pang, Y., Kiba, H., and Jayaraman, A. (1993) Acute nicotine injections induced c-fos mostly in non-dopaminegic cells of the midbrain of the rat. Mol. Brain Res. 20, 162–170.
Mathieu-Kia, A. M., Pages, C., and Besson, M. J. (1998) Inducibility of c-Fos protein in visuomotor system and limbic structures after acute and repeated administration of nicotine in the rat. Synapse 29, 343–354.
Watanabe, K. I., Hashimoto, K., Nishimura, T., Tsunashima, K. I., and Minabe, Y. (1998) Expression of Fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine. Brain Res. 797, 135–142.
Kiba, H. and Jayaraman, A. (1994) Nicotine induced c-fos expression in the striatum is mediated mostly by dopaminergic D1 receptor and is dependent on NMDA stimulation. Mol. Brain Res. 23, 1–13.
Nisell, M., Nomikos, G. G., Chergui, K., Grillner, P., Svesson, T. H. (1997) Chronic nicotine enhances basal and nicotine-induced Fos immunoreactivity preferentially in the medial prefrontal cortex of the rat. Neuropsychopharmacology 17,151–161.
Pagliusi, S. R., Tessari, M., DeVevey, S., Chiamulera, C., and Merlo Pich, E. (1996) The reinforcing properties of nicotine are associated with a specific patterning of c-fos expression in the rat brain. Eur. J. Neurosci. 8, 2247–2256.
Merlo Pich, E., Pagliusi, S. R., Tessari, M., Talabot-Ayer, D., Hooft van Huijsduijnen, R., and Chiamulera, C. (1997) Common neural substrates for the addictive properties of nicotine and cocaine. Science 275, 83–86.
Dobranzki, P., Nouguchi, T., Kovary, K., Rizzo, C., Lazo, P. S., and Bravo, R. (1991) Both products of the fosB gene, fosB and its short form, FosB/SF, are transcriptional activator in fibroblasts. Mol Cell Biol. 11, 2063–2069.
Schena, M. (1995), Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270,467–470.
Konu, O., Kane, J. K., Barrett, T., Vawter, M. P., Chang, R. Y., Ma, J. Z., Donovan, D. M., Sharp, B., Becker, K. G., and Li, M. D. (2001) Region-specific transcriptional response to chronic nicotine in rat brain. Brain Res. 909, 194–203.
Sacaan, A. L., Dunlop, J. L., and Loyd, G. K. (1995) Pharmacological characterisation of neuronal acetylcholine gated ion channel-receptors mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther. 274, 224–230.
Clarke, P. B. S. and Reuben, M. (1996) Release of [3H]-noradrenaline form rat hippocampal synaptosomes by nicotine, mediation from different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br. J. Pharmacol. 117, 595–606.
Brazel, M. P., Mitchell, S. N., and Gray, J. A. (1991) Effects of acute administration of nicotine on the in vivo release of noradrenaline in the hippocampus of freely moving rats, dose response and antagonism studies. Neuropharmacology 30, 823–833.
Mitchell, S. N., Smith, K. M., Joseph, M. H., and Gray, G. A. (1993) Increases of thyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activities and noradrenaline release. Neuroscience 56, 989–997.
Fu, Y., Matta, S. G., and Sharp, B. M. (1999) Local α-bungarotoxine-sensitive nicotinic receptors modulate hippocampal norepinephrine release by systemic nicotine. J. Pharmacol. Exp. Ther. 289,133–139.
Rosencrans, J. A. and Meltzer, L. T. (1981) Central sites and mechanisms of action of nicotine. Neurosci. Biobehay. Rev. 5, 497–501.
Holmes, K. J. and Spencer, C. M. (2000) Bupropion, a review of its use in the management of smoking cessation. Drugs 59,1007–1024.
Amit, Z., Smith, B. R., and Gill, K. (1991) Serotonin uptake inhibitor, effects of motivated consummatory behavior. J. Clin. Psychiatr. 52(Suppl.), 55–61.
Parsons, L. H., Weiss, F., and Koob, G. F. (1998) Serotonin 1B receptor stimulation enhances cocaine reinforcement. J. Neurosci. 18, 10078–89.
Corrigall, W. A. and Coen, K. M. (1994) Nicotine self-administration and locomotor activity are not modified by the 5-HT3 antagonist ICS205–930 and MDL722222. Pharmacol. Biochem. Behay. 49, 67–71.
Sannerud, C. A., Prada, J., Goldberg, D. M., and Goldberg, S. M. (1994) The effects of sertraline on nicotine self-administrationand food-maintained responding in squirrel monkeys. Eur. J. Pharmacol. 271, 461–469.
Zacny, J. P., Apfelbaum, J. L., Lichtor, J. L., and Zacaroza, J. G. (1993) Effects of 5hydroxythriptamine-3 receptor antagonist, ondansetron, on cigarette smoking, smoke exposure, and mood in humans. Pharmacol. Biochem. Behay. 44, 387–391.
Carboni, E., Aquas, E., Leone, P., and Di Chiara, G. (1989) 5-HT3 receptor antagonist ondansetron blocks morphine- and nicotine- but not amphetamine- induced reward. Psychopharmacology 97, 175–178.
Blondal, T., Gudmundsson, L. J., Tomasson, K., Jonsdottir, D., Hilmarsdottir, H., Kristjansson, F., Nilsson, F., and Bjornsdottir, U.S. (1999) The effects of fluoxetine combined with nicotine inhalers in smoking cessation, a randomized trial. Addiction 94,1007–1015.
Engberg, G. (1989) Nicotine induced excitation of locus coeruleus neurons is mediated via release of excitatory amino acids. Life Sci. 44, 1535–1540.
Shoaib, M., Benwell, M. E. M., Akbar, M. T., Stolerman, I. P., and Balfour, D. J. K. (1994) Behavioral and neurochemical adaptation to nicotine in rats: influence of NMDA antagonists. Br. J. Pharamcol. 111, 1073–1080.
Rosenceans, J. A., Hendry, S. G., and Hong, J. S. (1985) Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive β-endorphins in the mouse. Pharmacol. Biochem. Behay. 23, 141–143.
Houdi, A. A., Dasgupta, R., and Kindly, M. S. (1998) Effects of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res. 799, 257–263.
Dhatt, R. K., Gudehithlu, K. P., Wemlinger, T. A., Tewjani, G. A., Neff, N. H., and Hdjiconstantinou, M. (1995) Preproenkephalin mRNA and methionine-enkephalin contant are increased in mouse striatum after treatment with nicotine. J. Neurochm. 64, 1878–1883.
Mathieu-Kia, A. M. and Besson, M. J. (1998) Repeated administration of cocaine, nicotine and ethanol, effects on preprodynorphin, preprotachynin A, and preproenkephalin nRNA expression in the dorsal and ventral striatum of the rat. Mol. Brain Res. 54, 141–151.
Gorelik, D. A., Rose, J. E., and Jarvik, M. E. (1989) Effects of naloxone on cigarette smoking. J. Subst. Abuse 1, 153–159.
Karras, A. and Kane, J. M. (1980) Naloxone reduces cigarette smoking. Life Sci. 27, 1541–1545.
Nemeth-Coslett, R. and Griffith, R.R. (1986) Naloxone does not affect cigarette smoking. Psychopharmacology 89, 261–264.
Corrigal, W. A., Coen, K. M., Adamson, K. L., Chow, B. L., and Zhang, J. (2000) Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacologia 149, 107–114.
Kayadjanian, N., Retaux, S., Menetrey, A., and Besson, M. J. (1994) Stimulation by nicotine of the spontaneous release of [3H]gamma-aminobutyric acid in the substantia nigra and in the globus pallidus of the rat. Brain Res. 649, 129–135.
Alkondon, M., Pereira, E. F., Barbosa C. T., and Albunquerque, E. X. (1997) Neuronal nicotinic acetylcholine receptor activation modulates amma-aminobutyric acid release from CA 1 neurons of rat hippocampal slices. J. Pharmacol. Exp. Ther. 283, 1396–1411.
Lu, Y., Grady, S., Marks, M. J., Picciotto, M., Changeux, J. P., and Colins, A. C. (1998) Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 287, 648–657.
Fattore, L., Cossu, G., Martellotta, M. C., Deiana, S., and Fratta, W. (2001) Baclofen antagonises intravenous self-administration of gammahydroxybutyric acid in mice. Neuroreport 12, 2243–2246.
Cousins, M. S., Stamat, H. M., and de Wit, H. (2001) Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine & Tobacco Res. 3, 23–129.
Dewey, S. L., Brodie, J. D., Gerasimov, M., Horan, B., and Ashby, C. R., Jr. (1999) A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31, 76–86.
Wickelgren, I. (1998) Drug may suppress the craving for nicotine. Science 282, 1797–1799.
Sullivan, P. F., Jiang, Y., Neale, M. C., Kendler, K. S., and Straub, R. E. (2001) Association of the tryptophan hydroxylase gene with smoking initiation but not progression to nicotine dependence. Am. J. Med. Gen. 105, 479–484.
McKinney, E. F., Walton, R. T., Yudkin, P., Fuller, A., Haldar, N. A., Man, D., Murphy, M., Welsh, K. I., and Marshall, S. E. (2000) Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 10, 483–491.
Comings, D. E. and Blum, D. E. (2000) Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog. Brain Res. 126, 325–341.
Stitzel, J. A., Lu, Y., Jimenez, M., Tritto, T., and Collins, A. C. (2000) Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors. Behay. Brain Res. 113, 57–64.
Mohammed, A. H. (2000) Genetic dissection of nicotine-related behavior: a review of animal studies. Behay. Brain Res. 113, 35–41.
Heyser, C. J., McDonald, J. S., Beauchamp, V., Koob, G. F., and Gold, L. H. (1997) The effects of cocaine on operant responding for food in several strains of mice. Psychopharmacology 132, 202–208.
Deroche, V., Caine, S. B., Heyser, C. J., Polis, I., Koob, G. F., and Gold, L. H. (1997) Differences in the liability to self—administer intravenous cocaine between C57BL/6 x SJL and BALB/cByJ mice. Pharmacol. Biochem Behay. 57, 429–435.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pich, E.M., Heidbreder, C., Mugnaini, M., Teneggi, V. (2003). Molecular and Behavioral Aspects of Nicotine Dependence and Reward. In: Maldonado, R. (eds) Molecular Biology of Drug Addiction. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-343-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-59259-343-9_16
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-330-5
Online ISBN: 978-1-59259-343-9
eBook Packages: Springer Book Archive